Pakistan’s interim Health Minister, Dr. Nadeem Jan, revealed plans to establish a ‘Pharma Park’ in the country to encourage local production of pharmaceutical molecules instead of relying on imports.
Astellas Pharma Inc. has announced plans to build a new state-of-the-art facility in Tralee, Co. Kerry, Ireland, with an approximate cost of €330 million.
Eli Lilly and Purdue University have initiated a scholarship programme to enhance diversity in pharmaceutical education and industry.
The ABPI UK Pharma Reputation Index reveals that the public’s positive sentiment towards the pharmaceutical sector continues, with 67% acknowledging its commitment to creating new medicines for patient needs.
Royalty Pharma has secured a synthetic royalty deal with Ferring Pharmaceuticals for the gene therapy adstiladrin (nadofaragene firadenovec-vncg).
The Indian government has unveiled a scheme focused on fostering research and innovation in the pharmaceutical and medical technology (medtech) realms.
The Danish pharmaceutical company Novo Nordisk is set to acquire Inversago Pharma, a privately held obesity drug manufacturer, for a potential sum of $1.08 billion.
Grünenthal GmbH and Kyowa Kirin Co. have successfully formed a joint venture collaboration to create a new entity named Grünenthal Meds.
Takeda Pharmaceutical, Japan’s major pharmaceutical company, surpassed analysts’ expectations with a strong first-quarter profit.
Gland Pharma Ltd., a pharmaceutical company, experienced a surge in its stock prices following the approval of its drug application by the U.S. Food and Drug Administration (FDA).
Pakistan’s interim Health Minister, Dr. Nadeem Jan, revealed plans to establish a ‘Pharma Park’ in the country to encourage local production of pharmaceutical molecules instead of relying on imports.
Astellas Pharma Inc. has announced plans to build a new state-of-the-art facility in Tralee, Co. Kerry, Ireland, with an approximate cost of €330 million.
Eli Lilly and Purdue University have initiated a scholarship programme to enhance diversity in pharmaceutical education and industry.
The ABPI UK Pharma Reputation Index reveals that the public’s positive sentiment towards the pharmaceutical sector continues, with 67% acknowledging its commitment to creating new medicines for patient needs.
Royalty Pharma has secured a synthetic royalty deal with Ferring Pharmaceuticals for the gene therapy adstiladrin (nadofaragene firadenovec-vncg).
The Indian government has unveiled a scheme focused on fostering research and innovation in the pharmaceutical and medical technology (medtech) realms.
The Danish pharmaceutical company Novo Nordisk is set to acquire Inversago Pharma, a privately held obesity drug manufacturer, for a potential sum of $1.08 billion.
Grünenthal GmbH and Kyowa Kirin Co. have successfully formed a joint venture collaboration to create a new entity named Grünenthal Meds.
Takeda Pharmaceutical, Japan’s major pharmaceutical company, surpassed analysts’ expectations with a strong first-quarter profit.
Gland Pharma Ltd., a pharmaceutical company, experienced a surge in its stock prices following the approval of its drug application by the U.S. Food and Drug Administration (FDA).
According to Business Wire, global Healthcare Industry will be worth $12T by 2022. Healthcare is vast and highly fragmented with a mix of public and private players. It comprises patients and healthcare providers such as hospitals, pharmaceuticals, and related life sciences.
Digitisation and Post-Covid world are set to transform the healthcare industry in the coming decade. Our weekly business newsletter covers innovations and disruptions in the Healthcare industry with global coverage.
HealthGeniuses is managed by IndustryGeniuses (A place where industries meet innovation). We are rolling out content platforms for the world’s hottest industries such as Food & Grocery Retail, Consumer Goods and Healthcare. For each of these key industries, we support Tech Startups and Industry Disruptors as they roll out next generation digital initiatives.
IndustryGeniuses team brings practical domain knowledge of working with 300+ tech startups and brands over the past decade.